Wednesday, November 18, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

Marcus Chen

106 stories · Page 2 of 5

Infectious Disease

A Siberian Plague Lab Lost a Scientist, and Moscow Is Asking for the Trust It Burned at Sverdlovsk

Daria Shipilova, 28, studied plague in Irkutsk until a severe pneumonia killed her, and about 200 people were quarantined. The biology says stay calm. The history says make Moscow show its work.

Drugs & FDA

The FDA's Former Biologics Chief Says Public Health Can't See the Next Disaster Coming

Vinay Prasad ran the FDA's biologics center until this spring. His warning: the apparatus chases lettuce recalls and measles while a blood test for dozens of cancers heads toward Medicare with its central question unanswered.

Investigations

The MAHA Summit Charged Corporations Up to $300,000 for a Seat Beside the Officials Who Regulate Them

UnitedHealth got a panel. Grail, whose cancer test sat before the FDA, helped foot the bill. The regenerative ranchers and pesticide experts were nowhere on the program.

Investigations

The Fibroid Procedure That Spares the Uterus: Its Best Head-to-Head Evidence Was Paid For by the Device Maker

Radiofrequency ablation matched myomectomy on two-year symptom relief in a randomized trial. The device maker paid for that trial, and the durability question it cannot answer is the one that matters most.

Infectious Disease

Months After the FDA Recalled These Frozen Clams, No One Can Say Which Ecuadorian Waters Contaminated Them

Thirty-seven people across four states, thirty of them hospitalized, all linked to La Serranita black-shell clams imported frozen from Ecuador. The source waters are still under investigation.

Investigations

The Study Being Used to Close the Vaccine-Death Question Can't Rule Out Zero Excess Deaths in New Zealand

New Zealand's headline pandemic death study was co-authored by one of the country's most visible COVID modellers, and its four-year estimate runs from 1,134 fewer deaths than expected to 2,927 more. The modellers are calling it settled.

Drugs & FDA

Four Years After Congress Dropped the Animal-Testing Requirement for New Drugs, the FDA Finally Updated Its Rulebook to Match

The FDA's direct final rule swaps 'animal studies' for 'nonclinical studies' across its regulations. It eliminates no animal testing, moves no evidentiary bar, and sets up no program to prove the alternatives it now invites actually work.

Investigations

Brain on Fire: Ottawa's Vaccine-Injury Program Spent More on Its Contractor Than on the Injured

Fifty injured Canadians testified in Ottawa over four days, and Health Canada did not show. The compensation program has spent more on its contractor's overhead than on the people it was built to pay.

Infectious Disease

Czech Trust in Government Fell to 19 Percent. Eight to Ten Weeks Later, the Death Rate Pulled Away from Austria's.

A populist government overstated its testing, cycled through health ministers, and governed by press conference. Czechs stopped believing it, and a new analysis ties that collapse of faith to a death rate that ran roughly twice the European average.

Investigations

Fifty Sworn Witnesses, 1,400 Who Applied, and Not One Official From Health Canada

A sitting MP put Canadians who say the COVID shots injured them under oath on Parliament Hill. Health Canada, which authorized the products and tracks their harms, sent no one.

Investigations

The Last Time Moderna's Stock Soared on Vaccine News, Insiders Sold $400 Million. It's Happening Again.

Moderna's stock has run up 137 percent in a month on a melanoma-vaccine trial that has not released its detailed data or reported overall survival. As retail chased the rally, the CEO sold $28.7 million in shares two weeks before the readout, and the rest of the C-suite cashed out after the stock tr

Drugs & FDA

Twenty Years, Four Botanical Drugs: The FDA Wants to Know What's Blocking the Rest

Four botanical drugs in two decades, under a framework built for single molecules. Now, inside RFK Jr.'s HHS, the agency that wrote those rules is asking what blocked the rest, and whether it means it.

Drugs & FDA

A Fatal Brain Disease in Children Finally Has a Drug, and It Lists at $1.14 Million a Year

Ionis's zilganersen is the first therapy ever approved for Alexander disease, and it lists near $1.14 million a year. The same FDA approval handed Ionis a rare pediatric disease voucher, the transferable coupon that has resold for as much as $350 million.

Metabolic & Weight

The Heart Scan Sold to Everyone Barely Beats a Free Calculator, Except for the Patients Insurers Won't Cover

The scan barely moved the needle over a free calculator for most adults, but inside the muddy middle of risk, calcium separated a 1.9 percent ten-year danger from a 14.3 percent one.

Drugs & FDA

Sickle Cell Finally Has a Cure. It Costs $2.2 Million and Has Reached 64 People.

Casgevy has kept Victoria Gray crisis-free for seven years. Getting it still means wiping out a patient's bone marrow with a chemo tied to infertility and malignancy warnings and paying about $3 million all in, and two years after approval only 64 people have been infused.

Infectious Disease

The FDA Is Fighting a Flesh-Eating Parasite We Eradicated in 1966 With a Flea Pill From 2000

Nitenpyram was approved in 2000 to kill fleas. It is now the emergency tool against a parasite the United States wiped out in 1966, after the sterile-fly barrier that kept the screwworm out was breached in 2023.

Nutrition & Food

Sprouts Have Poisoned Thousands for a Quarter Century. The Wellness World Still Eats Them Raw.

Salmonella from Idaho broccoli sprouts has sickened 22 across four states, one more entry in a tally that logged 53 sprout outbreaks in two decades. The raw-is-best dogma is what keeps them coming.

Investigations

The Startup Selling 'Optimized' Babies Just Paid to Gene-Edit Human Embryos

Columbia scientists rewrote cholesterol and sickle-cell genes in human embryos, reaching 100 percent in embryos edited before their first division. The funder sells parents 'optimized' babies, and a germline edit like this could be inherited by every generation that follows.

Infectious Disease

A 2014 Trial Warned That Correcting Vaccine Fears Backfires on the Hesitant. Public Health Corrected Harder.

A randomized trial found that correcting MMR-autism fears left the most hesitant parents less likely to vaccinate. A decade later, a panel of credentialed doctors in Sydney shows the trust cost of correcting harder anyway.

Drugs & FDA

The FDA Has Approved 4 Plant Drugs Since 2004. Now It's Asking the Public Why So Few Made It.

A request for public input is not reform. After two decades of a pathway that produced four approvals, the question is whether the agency wants plant medicine or just wants to talk about it.

Infectious Disease

In 1999, Fifteen Reports Suspended a Vaccine Within Weeks. The Spike Signal Has Waited Years for a Study.

Spike protein has turned up in the vessel-lining cells of vasculitic skin lesions 18 months after the shot, and adverse-event reports keep stacking up. The agencies that suspended a vaccine over fifteen reports in 1999 now call thousands a coincidence.

Drugs & FDA

Ionis Priced the First Alexander Disease Drug at $1.14 Million a Year, and Got a Federal Voucher It Can Resell for More Than $100 Million

Zilganersen is the first drug for Alexander disease, an antisense therapy designed to lower the toxic protein that drives a fatal brain disease. It also carries a $1.14 million annual price and a pediatric voucher Ionis can resell for more than $100 million.

Investigations

An AI Read 4.4 Million Mother-and-Baby Records and Says It Can Predict Illness. It Has Yet to Meet a Living Patient.

MoChiAgent forecasts maternal and infant disease from hospital records at a scale no clinician could read. A cautionary predecessor, Epic's sepsis tool, caught only a third of the cases it promised to catch.

Investigations

Pennsylvania Announced Two Measles Deaths Its County Coroner Never Recorded

Pennsylvania classified two Lancaster County fatalities as measles-associated, including a newborn the county coroner says he certified as dying from a ruptured spleen and blood loss. The CDC won't add either to the national count until the record shows measles caused or contributed to the deaths.